Research News

TB Vaccine could be a valuable weapon in COVID-19 Fight : Researchers

  • Posted on: 3 April 2020
  • By: admin

The tuberculosis (TB) vaccine, Bacillus Calmette-Guerin (BCG), could be a potential weapon in combatting the deadly coronavirus according to findings published by NYIT College of Osteopathic Medicine (NYITCOM) researchers, led by Gonzalo Otazu, Ph.D., assistant professor of biomedical sciences.

Assam doctor died after taking hydroxychloroquine as prophylaxis

Assamese Doctor probably died of heart attack after taking anti-malarial drug as prophylaxis against novel corona virus (COVID-19). Anti-malarial drug, hydroxychloroquine, is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments.

Kidney patients are more vulnerable to COVID-19 infections

  • Posted on: 27 March 2020
  • By: admin

The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who receive regular haemodialysis. These patients with damaged kidneys, also known as uremic patients, are particularly vulnerable to infection and may exhibit greater variations in clinical symptoms and infectivity. 

Antimalarial drug is very effective against COVID-19

  • Posted on: 21 March 2020
  • By: PharmaTutor News

Scientists from France conducted a small clinical trials and reported that hydroxychloroquine, an antimalarial medicine, treatment is significantly associated with viral load reduction or disappearance in COVID-19 patients and they also reported that azithromycin along with hydroxychloroquine can faster the recovery.

COVID-19 is different in characteristics in children than adult : Research

  • Posted on: 18 March 2020
  • By: PharmaTutor News

In the early days of a COVID‐19 infection outbreak, pediatric patients were rather rare, who were thought to be not susceptible to it. However, along with the emerging of familial aggregation, children suffered from COVID‐19 infection were gradually appeared. It is reported by researchers that Clinical and CT (computed tomography) features in pediatric patients with COVID‐19 infection are different than adults. The study was conducted by Dr. Jianbo Shao, MD, Department of Imaging Center, Wuhan Children's Hospital and team. And it is published in Pediatric Pulmonology on 5th March, 2020.

New approach to speed up red blood cells generation in the lab

  • Posted on: 17 March 2020
  • By: PharmaTutor News

Transfusion of red blood cells (RBCs) is a life-saving treatment for numerous conditions such as severe anaemia, injury-related trauma, supportive care in cardiovascular surgery, transplant surgery, pregnancy-related complications, solid malignancies and blood-related cancers.

Scientists pave way for potential new therapy for tongue cancer

  • Posted on: 17 March 2020
  • By: PharmaTutor News

A new therapy for tongue cancer could be in the offing, with a team of scientists at the Department of Biotechnology’s Hyderabad-based Centre for DNA Fingerprinting and Diagnostics coming out with a new insight into the mechanism by which an anti-cancer protein helps in the development of cancer when it mutates.

COVID-19 vaccines trial started in USA with 45 patients

  • Posted on: 17 March 2020
  • By: PharmaTutor News

A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks.

Pages